BioPharma Drive: Drug Pricing

JUNE 26, 2025

and sold [Karuna],” wrote RBC Capital Markets analyst Brian Abrahams, in a note to clients. New data visualizations published by BioPharma Dive capture the year-to-date funding trends for 2025, which so far includes a significant pullback in financings for cancer drug developers. Sign up A valid email address is required.

Licensing 117

Licensing Licensing Therapies Vaccine 117

BioPharma Drive: Drug Pricing

JUNE 27, 2025

According to the FDA, these REMS requirements are no longer necessary to ensure safe use of these CAR-T therapies as both physicians and hospitals are now well versed in managing the two syndromes most commonly associated with the drugs. cell therapy market,” Daina Graybosch, an analyst at Leerink Partners, wrote in note to clients.

Therapies 178

Therapies FDA Treatment Licensing 178

Perficient: Drug Development

NOVEMBER 15, 2024

Healthcare Trend #1: AI Disruption and Enablement Healthcare has seen a surge of interest in AI, with the market set to soar to $187.95 Only then can data be richly woven into a reliable 360-degree view of the consumer that spans and supports better care management care management, marketing engagement, and support services.

Regulations 52

Regulations Compliance Production Nurses 52

Perficient: Drug Development

NOVEMBER 15, 2024

Healthcare Trend #1: AI Disruption and Enablement Healthcare has seen a surge of interest in AI, with the market set to soar to $187.95 Only then can data be richly woven into a reliable 360-degree view of the consumer that spans and supports better care management, marketing engagement, and support services. billion by 2030.

Regulations 64

Regulations Compliance Production Nurses 64

Perficient: Drug Development

MARCH 24, 2025

Marketo can be used for automated marketing campaigns, account nurturing, interactive webinars, and dynamic chat. CDP can be used to analyze data and build audiences for advertisements, merchandising, and abandoned cart campaigns. AJO can be used for personalized journeys and offers. These are just some of the possibilities!

Production 52

Production Engineering Marketing 52

Alta Sciences

JULY 3, 2025

MENU logo-altasciences EN - Main navigation Proactive Drug Development Solutions Compare Us Facilities About Us Resource Center Careers News & Events 30th Anniversary Celebration Contact Us Participate in a study Français Home Current: Business Leaders Review - The Heart and Strategy Behind Altasciences' Marketing Evolution Business Leaders (..)

Marketing 40

Marketing Pharmacokinetics Testimonials Biosimilars 40

BioPharma Drive: Drug Pricing

JUNE 23, 2025

The black and gray market risks Ben warned about the proliferation of counterfeit GLP-1 drugs in unregulated markets, posing significant dangers to patients who might unknowingly use ineffective or harmful products. The balance is complex, as obesity carries its own serious health risks.

Treatment 130

Treatment Drugs Therapies FDA 130

Fierce BioTech

APRIL 28, 2025

Accelerating Time-to-Market: Balancing Speed, Compliance, and Operational Excellence jpiatt Mon, 04/28/2025 - 14:42 Tue, 06/24/2025 - 10:00 Resource Type Webinar Promotion Start Thu, 05/01/2025 - 08:30 Promotion End Sat, 11/01/2025 - 08:30 In the highly competitive world of drug development, few things matter more than getting to market first.

Compliance 52

Compliance Marketing Drug Development Regulations 52

Alta Sciences

FEBRUARY 8, 2024

In this on-demand webinar, Ingrid Holmes , Vice President of Global Clinical Operations at Altasciences, and Dr. Gary G. Various psychomotor and neuropsychological tests, including the measurement of reaction time, divided attention, selective attention, and memory, may still be appropriate.

Clinical Trials 52

Clinical Trials Trials Clinical Pharmacology Clinical Development 52

Perficient: Drug Development

FEBRUARY 13, 2024

Learn about Adobe’s commitment to maintaining HIPAA-ready standards within commerce solutions and join Perficient and Adobe for a webinar hosted by CMSWire. EST Secure Digital Conversion: Unveiling Adobe’s HIPAA-Ready Commerce Solution webinar hosted by CMSWire. Register Today! Thursday, February 22 at 12:00 P.M.

Pharmacy 52

Pharmacy Science Regulations Marketing 52

The Pharma Data

SEPTEMBER 15, 2020

Find out solutions to mitigate the impact from clinical supply chain risk and discover how to improve dynamic drug supply forecasting strategies. Join this webinar to learn how supply forecasting and interactive response technology can help biotech companies improve supply planning and distribution while reducing cost and risk.

Clinical Supply 52

Clinical Supply Clinical Trials Doctors Clinical Development 52

PPD

SEPTEMBER 16, 2024

The convergence of real-world data (RWD), technology and artificial intelligence (AI) is playing a vital role in accelerating drug development. In a recent panel discussion at DIA Global , our experts explored how these elements are reshaping clinical research and drug discovery.

Clinical Development 98

Clinical Development Clinical Trials Clinical Research Drug Development 98

Perficient: Drug Development

OCTOBER 27, 2023

The webinar covered three pivotal aspects: Seamless Migration, Future-Ready Strategies, and the PWA Revolution. Seamless Migration: Composable Storefronts and Accelerators The webinar initiated with a comprehensive exploration of seamless migration strategies. The added assurance of SAP’s managed support promises stability.

Compliance 105

Compliance Marketing Licensing Licensing 105

Alta Sciences

JUNE 9, 2023

Accelerating Global Drug Development Timelines With Ethnobridging rmaloney Mon, 06/12/2023 - 16:07 HTML Safe Strategy to Save Time and Money Avoid repeating Phase I studies for drugs intended for the Asian market. Download your copy today. In this complimentary webinar , Mel B. Watch the webinar.

Drug Development 40

Drug Development Clinical Trials Biosimilars Pharmacokinetics 40

Alta Sciences

APRIL 17, 2024

Five Promising Treatment Areas in Early-Phase Drug Development in 2024 aasimakopoulos Wed, 04/17/2024 - 15:52 Early-phase drug development is an ever-changing landscape, as emerging science leads to new promising areas of research for the treatment of human health issues.

Drug Development 52

Drug Development Treatment Drugs FDA Approval 52

Conversations in Drug Development Trends

FEBRUARY 22, 2023

Our rare disease team at Worldwide will be hosting a panel discussion webinar with patient advocates active in Rare Disease Day events to synthesize the most salient conversations taking place. See their conversation below and register for the webinar to hear more from these advocates!

Disease 52

Disease Clinical Trials Trials Treatment 52

Fierce BioTech

OCTOBER 26, 2023

Are Gaps in Your Clinical Pharmacology Program Jeopardizing Your Drug’s Approval? pesurya Thu, 10/26/2023 - 14:05 Tue, 12/05/2023 - 11:00 Resource Type Webinar Julie Bullock, PharmD Krithika Shetty, PhD Blaire Osborn, Ph.D. png Listing Introduction Clinical pharmacology information comprises more than 50% of a drug label.

Clinical Pharmacology 52

Clinical Pharmacology Drug Development Regulations Marketing 52

Fierce BioTech

JANUARY 12, 2024

Developing and Manufacturing Minitablets to Extend Drug Lifecycle pesurya Fri, 01/12/2024 - 12:38 Wed, 02/28/2024 - 11:00 Resource Type Webinar Robert Strickley, PhD Valjon Demiri, MSc Duration 60 Minutes Oral minitablets can offer several advantages in pharmaceutical applications, making them a valuable option in drug delivery.

Drugs 52

Drugs Packaging Compliance Drug Development 52

Conversations in Drug Development Trends

FEBRUARY 26, 2024

However, incorporating the patient experience into your design is one of the best ways to ensure your drug development program is a commercial success. It plays a significant role in patient recruitment and retention, both of which are vital to maintaining timelines, decreasing program costs, and gaining market approval.

Clinical Trials 59

Clinical Trials Trials Disease Clinical Research 59

Conversations in Drug Development Trends

JUNE 13, 2024

At Worldwide, Matt Cooper and Jim Eamma , our Executive Directors, Therapeutic Strategy Leads in Oncology, shed light on the intricacies of modern oncology trials in their recent webinar, “ Navigating the Landscape of Complex & Adaptive Oncology Trials.” How Does Project Optimus Impact Your Study’s Operations?

Trials 52

Trials Clinical Trials Drug Development Clinical Development 52

Fierce BioTech

APRIL 4, 2024

Discover how leading organizations leverage AI to revolutionize operations and expedite drug development, ensuring faster access to life-saving treatments. Key Takeaways: Accelerate time-to-market by integrating AI-driven real-time visibility, streamlined workflows, and intelligent decision support. Click here to login.

Science 52

Science Compliance Drug Development Treatment 52

The Pharma Data

SEPTEMBER 9, 2020

We respect your privacy, by clicking “Download Your Copy” you will receive our e-newsletter, including information on Podcasts, Webinars, event discounts, online learning opportunities and agree to our User Agreement. Transition to advanced analytics platforms to accelerate a product’s time-to-market.

Production 52

Production Laboratories Compliance Government 52

Alta Sciences

MARCH 21, 2024

Watch Now The Altascientist: Central Nervous System Early-phase development of CNS-acting drugs is a complex, challenging undertaking. In this article, we provide a detailed overview of the multiple facets you need to consider during the planning and conduct of your CNS-active drug development.

Clinical Trials 40

Clinical Trials Trials Drug Development FDA 40

Fierce BioTech

OCTOBER 26, 2023

Separating the Science from the Fiction: Bringing the Lab of the Future to In Vivo Studies swheeler Thu, 10/26/2023 - 12:09 Thu, 12/07/2023 - 14:00 Resource Type Webinar Julie Morrison Ian Levine Jason M.

Science 52

Science Drug Development Research Drugs 52

Conversations in Drug Development Trends

MAY 1, 2024

This is a mechanism for experts to concurrently engage in scientific discourse with sponsors on key issues during the development phase of new medicinal products. Check out our recent webinar for a more comprehensive dive into early and ongoing regulatory engagement and how it drives program and commercial success. Japan, and China.

Clinical Research 69

Clinical Research Trials Clinical Trials Research 69

Perficient: Drug Development

OCTOBER 4, 2023

Tailor offers according to emerging trends and customer pain points through market research. Limited Marketing Resources: Leverage digital marketing and social media to cost-effectively reach a broader audience. Collaborate with complementary businesses for co-marketing opportunities.

Compliance 52

Compliance Government Production Marketing 52

Drug Target Review

DECEMBER 5, 2024

6 (CC BY 4) Overcoming traditional analytical barriers in capsid ratio determination While there are numerous analytical technologies available on the market for testing rAAV capsid ratios, none of the current methods are endorsed by regulatory agencies for large-scale product manufacturing. Bio-Rad, Bulletin 3725 [cited 2024 Oct 28].

Therapies 52

Therapies Virus DNA Compliance 52

Agency IQ

JULY 22, 2024

Facing headwinds, FDA moves ahead on diagnostics policy implementation but faces Congressional, legal, and judicial questions In April 2024, the FDA issued a final rule to update its regulatory approach to certain test products known as Laboratory Developed Tests (LDTs). AgencyIQ provides a status update for regulated industry.

FDA 40

FDA Laboratories Regulations Clinical Trials 40

The Connected Lab

JUNE 2, 2021

The impact of these technologies on drug development, production and logistics is so disruptive that many consider the sector to be entering a fourth industrial revolution, known as Pharma 4.0. Here, we look at how Pharma 4.0 Join our Laboratory 4.0 Digitalization and Internet of Laboratory Things Strategies to Enrich Industry 4.0

Pharmaceuticals 52

Pharmaceuticals Laboratories Pharmaceutical Companies Production 52

Perficient: Drug Development

FEBRUARY 27, 2024

Imagine this: You are a marketer at a medical device organization. It’s every marketer’s dream. Let’s look at a few ways medical device marketers can supercharge the digital product catalogs. Your products are cutting-edge, innovative, and best-in-class. Many of us remember the days of paper catalogs and brochures.

Production 52

Production Testimonials Marketing Science 52

The Pharma Data

DECEMBER 15, 2020

Company plans to meet with regulatory authorities as it evaluates next development steps. Company to host Key Opinion Leader (KOL) webinar to discuss these results today, December 16, at 8:00 am EST; registration link below. Interested parties can register for the webinar here. Kenilworth, N.J. ,

Clinical Trials 40

Clinical Trials Trials Treatment Therapies 40

Conversations in Drug Development Trends

FEBRUARY 28, 2023

Four decades later, Rob realized he had coincidentally dedicated his life — a life saved because of that charity — to driving life-saving treatments to market in the very same way, as the Executive Director of Uplifting Athletes. We are joining these researchers and patient communities on a decades-long journey to get a drug to market.

Clinical Trials 52

Clinical Trials Disease Trials Research 52

Agency IQ

NOVEMBER 3, 2023

The agency further proposed a five “stage” phaseout of its current enforcement discretion, which would walk in the medical device regulatory requirements – from adverse events reporting to pre-market review – over four years. Under the proposed rule, these tests would be able to continue operating under the current status quo.

FDA 40

FDA Laboratories Regulations Production 40

Perficient: Drug Development

JULY 18, 2023

The uncertain economy has also caused organizations to cut back on travel budgets – making webinars more attractive. It’s no wonder that many events have had lower post-pandemic attendance rates as people become increasingly wary about where and how they invest their time.

Research 52

Research Marketing 52

Agency IQ

AUGUST 23, 2024

At a high level, the establishment of OPEQ brought together previously disparate offices involved in pre-market review (the Office of Device Evaluation and its divisions) and post-market work related to compliance and surveillance (the Office of Compliance) and Office of Surveillance and Biometrics).

FDA 40

FDA Laboratories Regulations Clinical Trials 40

Agency IQ

AUGUST 2, 2024

Happy 40 th Birthday, generic drugs: September 24 will mark the 40 th anniversary of the 1984 signing of the Hatch-Waxman Act, which created a formal pathway for the approval of generic drugs. We expect the FDA to mark the occasion, especially since drug pricing continues to be such a potent issue in the Presidential election.

FDA 40

FDA Science Regulations Biosimilars 40

Perficient: Drug Development

FEBRUARY 11, 2024

At this time many of you may have heard about the official Sitecore Mentor Program , run by Nicole Montero from the Sitecore Technical Marketing Team. Mentor Program celebrates its second year with a significant growth of positive outcomes and success stories from both mentors and mentees.

Compliance 52

Compliance Marketing 52